查看購物車
  • Simplified Chinese
  • English
  • Japanese
製藥設備市場：按最終產品類型、設備類型和地區分類 - 到 2029 年的預測
市場調查報告書
商品編碼
1614458

製藥設備市場：按最終產品類型、設備類型和地區分類 - 到 2029 年的預測

Pharmaceutical Manufacturing Equipment Market by Machine (Mixing & Blending, Milling, Spray Drying, Granulation, Extrusion, Tablet Compression, Sterilization, and Inspection), Process (Encapsulation, Formulation, Aseptic) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 247 Pages | 訂單完成後即時交付

價格

全球製藥設備市場規模預計將從2024年的194.1億美元成長到2029年的269.4億美元，預測期間內複合年成長率為6.8%。

學名藥的需求不斷成長正在推動製藥設備市場的成長。另一方面，再製造設備的需求正在抑制製藥設備市場的成長。

調查範圍
調查年份 2020-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（十億美元）
按細分市場 依最終產品類型、設備類型和地區
目標區域 北美、歐洲、亞太等地區

由於幾個關鍵因素，包裝機械領域預計將成為製藥設備市場中複合年成長率最高的領域。預填充式注射器、單劑量管瓶和泡殼包裝等創新藥物傳遞形式在製藥業中越來越重要，需要先進且複雜的包裝解決方案。此外，採用先進的包裝技術（例如序列化和防篡改解決方案）滿足了藥品安全和可追溯性的嚴格監管要求。此外，隨著以患者為中心的醫療保健趨勢不斷成長，包裝在提高用戶便利性和合規性方面發揮著重要作用。生技藥品、個人化藥物和疫苗的成長也需要高精度和無菌的包裝環境，進一步推動了對先進包裝機器的需求。

由於監管重點關注兒科製劑，預計液體細分市場將以複合年成長率成長。美國食品藥物管理局(FDA) 等監管機構強調需要適合年齡的液體藥物，以解決兒童在吞嚥錠劑和膠囊等固態劑型時所面臨的挑戰。這種推動提高了兒科治療的依從性、安全性和有效性，並推動了對液體劑型的強勁需求。此外，液體製劑可實現精確劑量，使其成為需要客製化劑量的兒科和其他患者的理想選擇。人們對兒科藥物日益濃厚的興趣正在推動製藥公司創新液體配方並開拓新的市場機會。

該地區的特點是競爭激烈，由大型製藥公司和中小型公司主導，這反過來又促進了產品創新和多元化。對新製造技術研發的大量投資支持了該市場在該地區的主導地位。生物製藥引發了產業的重大轉變，徹底改變了整個歐洲。德國是歐盟核准的最大的生物製藥物質生產國。這一成長與生技藥品收益的增加相一致，進一步加強了歐洲製藥設備市場。

該報告研究了全球製藥設備市場，包括最終產品類型、設備類型、地區和進入市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 影響客戶業務的趨勢/干擾
  • 價格分析
  • 價值鏈分析
  • 生態系分析
  • 人工智慧/產生人工智慧對製藥設備市場的影響
  • 技術分析
  • 專利分析
  • 貿易分析
  • 2025-2026年重大會議和活動
  • 案例研究
  • 監管環境
  • 波特五力分析
  • 主要相關人員和採購標準

第6章 藥品生產設備供應商及售後供應商

  • 介紹
  • OEM
  • 售後供應商

第7章 製藥器材主要製造工序

  • 介紹
  • 配方流程
  • 錠劑和封裝工藝
  • 無菌過程
  • 包裝工藝
  • 品管流程

第8章 藥品生產設備的最終用戶

  • 介紹
  • 藥品製造商
  • CMO

第9章製藥設備市場（依最終產品類型）

  • 介紹
  • 固體的
  • 液體

第10章製藥設備市場（依設備類型）

  • 介紹
  • 包裝器材
  • 灌裝機
  • 噴霧乾燥機
  • 混合/混合機
  • 銑削設備
  • 擠出設備
  • 壓片錠劑
  • 檢驗設備
  • 製粒設備
  • 消毒器

第11章製藥設備市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟前景
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲宏觀經濟展望
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他
  • 其他領域
    • 其他地區宏觀經濟展望
    • 中東
    • 非洲
    • 南美洲

第12章競爭格局

  • 概述
  • 主要參與企業的策略/優勢，2022-2024
  • 2019-2023年收益分析
  • 2023 年市場佔有率分析
  • 2024年企業評價與財務指標
  • 品牌/產品比較
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 競爭場景

第13章 公司簡介

  • 主要參與企業
    • GEA GROUP AKTIENGESELLSCHAFT
    • IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
    • SYNTEGON TECHNOLOGY GMBH
    • ACG
    • THERMO FISHER SCIENTIFIC INC.
    • ROMACO GROUP
    • KORBER AG
    • MARCHESINI GROUP SPA
    • MG2 SRL
    • GLATT GMBH
  • 其他公司
    • BAUSCH+STROBEL SE+CO. KG
    • COPERION GMBH
    • ELIZABETH COMPANIES
    • FETTE COMPACTING
    • FREUND
    • KORSCH AG
    • LB BOHLE MASCHINEN UND VERFAHREN GMBH
    • LFA MACHINES
    • CVC TECHNOLOGIES, INC.
    • OHARA TECHNOLOGIES
    • PRISM PHARMA MACHINERY
    • SAINTYCO
    • SILVERSON
    • YENCHEN MACHINERY CO., LTD
    • QUALICAPS
    • COESIA SPA
    • UHLMANN
    • AUTOMATED SYSTEMS OF TACOMA, LLC

第14章附錄

Product Code: SE 8645

The global pharmaceutical manufacturing equipment market size is projected to grow from USD 19.41 billion in 2024 to USD 26.94 billion in 2029, recording a CAGR of 6.8% during the forecast period. Rising demand for generic drugs is driving the growth of the pharmaceutical manufacturing equipment market. Whereas the demand for refurbished equipments is restraining the growth of the pharmaceutical manufacturing equipment market.

Scope of the Report
Years Considered for the Study2020-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsBy equipment type, end-product type, process, end user, supplier type, and region
Regions coveredNorth America, Europe, APAC, RoW

"Packaging machines segment is expected to witness highest CAGR during the forecasted period in pharmaceutical manufacturing equipment market."

The packaging machines segment is expected to have the highest CAGR in the pharmaceutical manufacturing equipment market due to a few critical factors. Innovative drug delivery formats such as pre-filled syringes, single-dose vials, and blister packs are gaining much importance in the pharmaceutical industry, which requires advanced and sophisticated packaging solutions. In addition, adoption of sophisticated packaging technologies, such as serialization and tamper-evident solutions, is stringent regulatory requirements for drug safety and traceability. It is also due to the growing trend of patient-centric healthcare, where packaging is playing an important role in enhancing user convenience and compliance. The growth in biologics, personalized medicines, and vaccines also requires highly precise and sterile packaging environments, thereby further driving demand for advanced packaging machines.

"Liquid segment is likely to witness highest CAGR in pharmaceutical manufacturing equipment market during forecasted period ."

The liquid segment is witnessing the CAGR due to regulatory emphasis on pediatric formulations. Regulatory bodies such as the US Food and Drug Administration (FDA) have stressed the need for age-appropriate liquid medications to address the challenges children face with swallowing solid forms like tablets and capsules. This push ensures better compliance, safety, and efficacy in pediatric treatments, significantly driving demand for liquid dosage forms. Additionally, liquid medications allow precise dosing, making them ideal for children and other patients requiring tailored administration. The growing focus on pediatric health has led pharmaceutical companies to innovate in liquid formulations, opening new market opportunities.

"Europe is expected to hold the second largest market share of the pharmaceutical manufacturing equipment market during forecasted period".

The region is marked by a very competitive landscape, dominated by both large pharmaceutical companies and SMEs, thus facilitating innovation and diversification in terms of products. A tremendous investment in R&D for new manufacturing technologies supports the region's dominance in this market. Biopharmaceuticals form a great shift in the industry and have transformed it across Europe; Germany has emerged to be the largest producer of EU-approved biopharmaceutical substances. This growth is matched by increasing revenues from biologics, which further strengthens the the pharmaceutical manufacturing equipment market in Europe.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Company Type - Tier 1 - 40%, Tier 2 - 35%, Tier 3 - 25%
  • By Designation- C-level Executives - 45%, Directors - 35%, Others - 20%
  • By Region-North America - 30%, Europe - 25%, Asia Pacific - 40%, RoW - 5%

The pharmaceutical manufacturing equipment market is dominated by a few globally established players such as GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India), Korber AG (Germany), Thermo Fisher Scientific Inc. (US), Marchesini Group (Italy), MG2 s.r.l (Italy), Glatt GmbH (Germany). The study includes an in-depth competitive analysis of these key players in the pharmaceutical manufacturing equipment market, with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the pharmaceutical manufacturing equipment and forecasts its size by equipment type, end product type, and region. The report also discusses the drivers, restraints, opportunities, and challenges pertaining to the market. It gives a detailed view of the market across four main regions-North America, Europe, Asia Pacific, and RoW. Supply chain analysis has been included in the report, along with the key players and their competitive analysis in the pharmaceutical manufacturing equipment ecosystem.

Key Benefits to Buy the Report:

  • Analysis of key drivers (Rising demand for pharmaceuticals, technological advancements in equipment and growing implementation & adoption of regulatory guidelines). Restraint (Demand for refurbished equipment), Opportunity (Growth in personalized medicines), Challenges (Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment).
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pharmaceutical manufacturing equipment market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the pharmaceutical manufacturing equipment market across varied regions
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India) among others in the pharmaceutical manufacturing equipment market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNIT CONSIDERED
  • 1.6 STAKEHOLDERS
  • 1.7 LIMITATIONS
  • 1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 List of primary interview participants
      • 2.1.2.2 Breakdown of primaries
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Key industry insights
    • 2.1.3 SECONDARY AND PRIMARY RESEARCH
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach to arrive at market size through bottom-up analysis (demand side)
    • 2.2.2 TOP-DOWN APPROACH
      • 2.2.2.1 Approach to arrive at market size through top-down analysis (supply side)
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • 4.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
  • 4.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
  • 4.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing rate of chronic diseases
      • 5.2.1.2 Adoption of modular manufacturing setups
      • 5.2.1.3 Increasing implementation and adoption of regulatory guidelines
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Rising adoption of refurbished equipment
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for personalized medicines
      • 5.2.3.2 Rising demand for biopharmaceuticals
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Adherence to multiple regulations and standards
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    • 5.4.1 INDICATIVE PRICING OF KEY PLAYERS, BY EQUIPMENT TYPE, 2023
    • 5.4.2 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019-2023
    • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION, 2019-2023
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Digital twin
      • 5.8.1.2 Automation and robotics
      • 5.8.1.3 IoT
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
      • 5.8.2.1 3D printing
    • 5.8.3 ADJACENT TECHNOLOGIES
      • 5.8.3.1 CAD and CAM
  • 5.9 PATENT ANALYSIS
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA (HS CODE 842230)
    • 5.10.2 EXPORT DATA (HS CODE 842230)
  • 5.11 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.12 CASE STUDIES
    • 5.12.1 ZAMBON COMPANY S.P.A. AND IMA ACTIVE COLLABORATED ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY
    • 5.12.2 ACG HELPED INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM
    • 5.12.3 SYNTEGON PROVIDED JIANGSU WITH AIM 5022S PLATFORM TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY
  • 5.13 REGULATIONS LANDSCAPE
    • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.13.2 STANDARDS
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 BARGAINING POWER OF SUPPLIERS
    • 5.14.2 BARGAINING POWER OF BUYERS
    • 5.14.3 THREAT OF NEW ENTRANTS
    • 5.14.4 THREAT OF SUBSTITUTES
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA

6 PHARMACEUTICAL MANUFACTURING EQUIPMENT SUPPLIERS AND AFTERMARKET SUPPLIERS

  • 6.1 INTRODUCTION
  • 6.2 ORIGINAL EQUIPMENT MANUFACTURERS
  • 6.3 AFTERMARKET SUPPLIERS

7 MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES

  • 7.1 INTRODUCTION
  • 7.2 FORMULATION PROCESS
  • 7.3 TABLETING AND ENCAPSULATION PROCESS
  • 7.4 ASEPTIC PROCESS
  • 7.5 PACKAGING PROCESS
  • 7.6 QUALITY CONTROL PROCESS

8 END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL MANUFACTURING COMPANIES
  • 8.3 CONTRACT MANUFACTURING ORGANIZATIONS

9 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE

  • 9.1 INTRODUCTION
  • 9.2 SOLID
    • 9.2.1 ONGOING TECHNOLOGICAL INNOVATIONS TO DRIVE MARKET
  • 9.3 LIQUID
    • 9.3.1 RISING APPLICATION FOR UNSTABLE DRUGS IN SOLID FORM TO BOOST DEMAND

10 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE

  • 10.1 INTRODUCTION
  • 10.2 PACKAGING MACHINES
    • 10.2.1 RISING NEED TO ENSURE PROTECTION AGAINST DAMAGE AND CONTAMINATION TO FUEL MARKET GROWTH
  • 10.3 FILLING MACHINES
    • 10.3.1 GROWING NEED FOR COMPLIANCE WITH STRINGENT REGULATORY STANDARDS TO FOSTER MARKET GROWTH
  • 10.4 SPRAY DRYING EQUIPMENT
    • 10.4.1 PRESSING NEED TO PRODUCE HIGH-QUALITY DRUG PRODUCTS TO FUEL MARKET GROWTH
  • 10.5 MIXING AND BLENDING MACHINES
    • 10.5.1 ABILITY TO PROVIDE CONTROLLED AND CONSISTENT AGITATION AND SHEAR FORCES TO ENSURE HOMOGENEITY OF DRUG FORMULATION TO BOOST DEMAND
  • 10.6 MILLING EQUIPMENT
    • 10.6.1 RISING NEED TO REDUCE PARTICLE SIZE OF DRUG FORMULATIONS TO FOSTER MARKET GROWTH
  • 10.7 EXTRUSION EQUIPMENT
    • 10.7.1 ELEVATING USE TO PRODUCE VARIOUS DOSAGE FORMS TO FUEL MARKET GROWTH
  • 10.8 TABLET COMPRESSION PRESSES
    • 10.8.1 INCREASING PREFERENCE FOR SOLID DOSAGE FORMS TO DRIVE MARKET
  • 10.9 INSPECTION EQUIPMENT
    • 10.9.1 SURGING NEED TO ENSURE QUALITY AND INTEGRITY OF DRUG PRODUCTS TO FOSTER MARKET GROWTH
  • 10.10 GRANULATION EQUIPMENT
    • 10.10.1 ABILITY TO IMPROVE OVERALL STABILITY AND BIOAVAILABILITY OF DRUGS TO BOOST DEMAND
  • 10.11 STERILIZATION EQUIPMENT
    • 10.11.1 GROWING DEMAND FOR CONTAMINATION-FREE DRUGS AND PRODUCTS TO DRIVE MARKET

11 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Government-led initiatives to advance pharmaceutical manufacturing capacity to drive market
    • 11.2.3 CANADA
      • 11.2.3.1 Rising emphasis on strengthening domestic manufacturing capabilities to foster market growth
    • 11.2.4 MEXICO
      • 11.2.4.1 Increasing focus on streamlining pharmaceutical regulatory processes to fuel market growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 UK
      • 11.3.2.1 Rising emphasis on developing advanced manufacturing equipment to offer lucrative growth opportunities
    • 11.3.3 GERMANY
      • 11.3.3.1 Escalating demand for branded and generic drugs to foster market growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Government-led policies to encourage investment and innovation in pharmaceutical manufacturing industry to accelerate demand
    • 11.3.5 ITALY
      • 11.3.5.1 Growing focus on establishing pharmaceutical manufacturing facilities to create significant growth opportunities
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 CHINA
      • 11.4.2.1 Surging FDIs and regulatory reforms to streamline drug approvals to offer lucrative growth opportunities
    • 11.4.3 JAPAN
      • 11.4.3.1 Increasing demand for innovative pharmaceutical manufacturing solutions to fuel market growth
    • 11.4.4 INDIA
      • 11.4.4.1 Government-led initiatives to strengthen domestic manufacturing to boost demand
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Low import tariffs and enhanced regulatory transparency to attract foreign investments to foster market growth
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 ROW
    • 11.5.1 MACROECONOMIC OUTLOOK FOR ROW
    • 11.5.2 MIDDLE EAST
      • 11.5.2.1 Expanding pharmaceutical manufacturing infrastructure to offer growth opportunities
      • 11.5.2.2 GCC
      • 11.5.2.3 Rest of Middle East
    • 11.5.3 AFRICA
      • 11.5.3.1 Rising investment in local pharmaceutical manufacturing to fuel market growth
    • 11.5.4 SOUTH AMERICA
      • 11.5.4.1 Introduction of tax incentives to strengthen pharmaceutical manufacturing to support market growth

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2024
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024
  • 12.6 BRAND/PRODUCT COMPARISON
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.7.5.1 Company footprint
      • 12.7.5.2 Region footprint
      • 12.7.5.3 Primary packaging equipment footprint
      • 12.7.5.4 Secondary packaging equipment footprint
      • 12.7.5.5 Type footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.8.5.1 Detailed list of key startups/SMEs
      • 12.8.5.2 Competitive benchmarking of key startups/SMEs
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES
    • 12.9.2 DEALS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 GEA GROUP AKTIENGESELLSCHAFT
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Solutions/Services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
        • 13.1.1.3.2 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths/Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses/Competitive threats
    • 13.1.2 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Solutions/Services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths/Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses/Competitive threats
    • 13.1.3 SYNTEGON TECHNOLOGY GMBH
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Solutions/Services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Product launches
        • 13.1.3.3.2 Deals
        • 13.1.3.3.3 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths/Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses/Competitive threats
    • 13.1.4 ACG
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Solutions/Services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Deals
        • 13.1.4.3.2 Expansions
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Key strengths/Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses/Competitive threats
    • 13.1.5 THERMO FISHER SCIENTIFIC INC.
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Solutions/Services offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Deals
        • 13.1.5.3.2 Expansions
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Key strengths/Right to win
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses/Competitive threats
    • 13.1.6 ROMACO GROUP
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Solutions/Services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches
        • 13.1.6.3.2 Deals
    • 13.1.7 KORBER AG
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Solutions/Services offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Deals
        • 13.1.7.3.2 Expansions
    • 13.1.8 MARCHESINI GROUP S.P.A.
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Solutions/Services offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches
        • 13.1.8.3.2 Deals
    • 13.1.9 MG2 S.R.L.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Solutions/Services offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches
    • 13.1.10 GLATT GMBH
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Solutions/Services offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 BAUSCH+STROBEL SE + CO. KG
    • 13.2.2 COPERION GMBH
    • 13.2.3 ELIZABETH COMPANIES
    • 13.2.4 FETTE COMPACTING
    • 13.2.5 FREUND
    • 13.2.6 KORSCH AG
    • 13.2.7 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH
    • 13.2.8 LFA MACHINES
    • 13.2.9 CVC TECHNOLOGIES, INC.
    • 13.2.10 OHARA TECHNOLOGIES
    • 13.2.11 PRISM PHARMA MACHINERY
    • 13.2.12 SAINTYCO
    • 13.2.13 SILVERSON
    • 13.2.14 YENCHEN MACHINERY CO., LTD
    • 13.2.15 QUALICAPS
    • 13.2.16 COESIA S.P.A.
    • 13.2.17 UHLMANN
    • 13.2.18 AUTOMATED SYSTEMS OF TACOMA, LLC

14 APPENDIX

  • 14.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 CUSTOMIZATION OPTIONS
  • 14.5 RELATED REPORTS
  • 14.6 AUTHOR DETAILS

List of Tables

  • TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RISK ANALYSIS
  • TABLE 2 INDICATIVE PRICING OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2023 (USD)
  • TABLE 3 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019-2023 (USD)
  • TABLE 4 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, BY REGION, 2019-2023 (USD)
  • TABLE 5 ROLES OF COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM
  • TABLE 6 LIST OF MAJOR PATENTS
  • TABLE 7 IMPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 8 EXPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 9 LIST OF KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 STANDARDS PERTAINING TO PHARMACEUTICAL MANUFACTURING EQUIPMENT
  • TABLE 15 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END-PRODUCT TYPES
  • TABLE 17 KEY BUYING CRITERIA FOR END-PRODUCT TYPES
  • TABLE 18 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 20 SOLID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 21 SOLID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 22 LIQUID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 23 LIQUID: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 24 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (THOUSAND UNITS)
  • TABLE 25 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (THOUSAND UNITS)
  • TABLE 26 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 27 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 28 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 29 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 30 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 31 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 32 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 33 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 34 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 35 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 36 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 37 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 38 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 39 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 40 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 41 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 42 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 43 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 44 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 45 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 46 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 47 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 48 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 49 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 50 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 51 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 52 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 53 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 54 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 55 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 56 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 57 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 58 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 59 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 60 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 61 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 62 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 63 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 64 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 65 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 66 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 67 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 68 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 69 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 70 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 71 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 72 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 73 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 74 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 75 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 76 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 77 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 78 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 79 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 80 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 81 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 82 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 83 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 84 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 85 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 86 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 87 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 88 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 89 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 90 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 91 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 92 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 93 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 94 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 95 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 96 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 97 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 98 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 99 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 100 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 101 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 102 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 103 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 104 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 105 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 106 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 107 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 108 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 109 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 110 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 111 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 112 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 113 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 114 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 115 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 116 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 117 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 118 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2020-2023 (USD MILLION)
  • TABLE 119 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2024-2029 (USD MILLION)
  • TABLE 120 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 121 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 122 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 123 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 124 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 125 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 126 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 127 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 128 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 129 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 131 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 133 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 134 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 135 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 136 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 137 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 138 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 139 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 140 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 141 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 142 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 143 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 144 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 145 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 146 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 147 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 148 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 149 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 151 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 156 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 157 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 158 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 159 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 160 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 161 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 162 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 163 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 164 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 165 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 166 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 167 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 168 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2020-2023 (USD MILLION)
  • TABLE 169 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2024-2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 171 MIDDLE EAST: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2022-2024
  • TABLE 173 PHARMACEUTICAL PACKAGING MACHINES MARKET: DEGREE OF COMPETITION, 2023
  • TABLE 174 PHARMACEUTICAL PACKAGING MACHINES MARKET: REGION FOOTPRINT
  • TABLE 175 PHARMACEUTICAL PACKAGING MACHINES MARKET: PRIMARY PACKAGING EQUIPMENT FOOTPRINT
  • TABLE 176 PHARMACEUTICAL PACKAGING MACHINES MARKET: SECONDARY PACKAGING EQUIPMENT FOOTPRINT
  • TABLE 177 PHARMACEUTICAL PACKAGING MACHINES MARKET: TYPE FOOTPRINT
  • TABLE 178 PHARMACEUTICAL PACKAGING MACHINES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 179 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 180 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2024
  • TABLE 181 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2022-OCTOBER 2024
  • TABLE 182 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
  • TABLE 183 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 184 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES
  • TABLE 185 GEA GROUP AKTIENGESELLSCHAFT: DEALS
  • TABLE 186 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: COMPANY OVERVIEW
  • TABLE 187 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: PRODUCT/SOLUTIONS/SERVICES OFFERED
  • TABLE 188 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.: DEALS
  • TABLE 189 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
  • TABLE 190 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 191 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES
  • TABLE 192 SYNTEGON TECHNOLOGY GMBH: DEALS
  • TABLE 193 SYNTEGON TECHNOLOGY GMBH: EXPANSIONS
  • TABLE 194 ACG: COMPANY OVERVIEW
  • TABLE 195 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 196 ACG: DEALS
  • TABLE 197 ACG: EXPANSIONS
  • TABLE 198 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 199 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 200 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 201 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
  • TABLE 202 ROMACO GROUP: COMPANY OVERVIEW
  • TABLE 203 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 204 ROMACO GROUP: PRODUCT LAUNCHES
  • TABLE 205 ROMACO GROUP: DEALS
  • TABLE 206 KORBER AG: COMPANY OVERVIEW
  • TABLE 207 KORBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 208 KORBER AG: DEALS
  • TABLE 209 KORBER AG: EXPANSIONS
  • TABLE 210 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW
  • TABLE 211 MARCHESINI GROUP S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 212 MARCHESINI GROUP S.P.A.: PRODUCT LAUNCHES
  • TABLE 213 MARCHESINI GROUP S.P.A.: DEALS
  • TABLE 214 MG2 S.R.L.: COMPANY OVERVIEW
  • TABLE 215 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 216 MG2 S.R.L.: PRODUCT LAUNCHES
  • TABLE 217 GLATT GMBH: COMPANY OVERVIEW
  • TABLE 218 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 219 BAUSCH+STROBEL SE + CO. KG: COMPANY OVERVIEW
  • TABLE 220 COPERION GMBH: COMPANY OVERVIEW
  • TABLE 221 ELIZABETH COMPANIES: COMPANY OVERVIEW
  • TABLE 222 FETTE COMPACTING: COMPANY OVERVIEW
  • TABLE 223 FREUND: COMPANY OVERVIEW
  • TABLE 224 KORSCH AG: COMPANY OVERVIEW
  • TABLE 225 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH: COMPANY OVERVIEW
  • TABLE 226 LFA MACHINES: COMPANY OVERVIEW
  • TABLE 227 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 228 OHARA TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 229 PRISM PHARMA MACHINERY: COMPANY OVERVIEW
  • TABLE 230 SAINTYCO: COMPANY OVERVIEW
  • TABLE 231 SILVERSON: COMPANY OVERVIEW
  • TABLE 232 YENCHEN MACHINERY CO., LTD: COMPANY OVERVIEW
  • TABLE 233 QUALICAPS: COMPANY OVERVIEW
  • TABLE 234 COESIA S.P.A.: COMPANY OVERVIEW
  • TABLE 235 UHLMANN: COMPANY OVERVIEW
  • TABLE 236 AUTOMATED SYSTEMS OF TACOMA, LLC: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION
  • FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN
  • FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES
  • FIGURE 4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: BOTTOM-UP APPROACH
  • FIGURE 5 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TOP-DOWN APPROACH
  • FIGURE 6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DATA TRIANGULATION
  • FIGURE 7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH ASSUMPTIONS
  • FIGURE 8 PACKAGING MACHINES TO HOLD DOMINANT MARKET SHARE IN 2029
  • FIGURE 9 SOLID SEGMENT TO CLAIM LARGEST MARKET SHARE IN 2024
  • FIGURE 10 ASIA PACIFIC DOMINATED MARKET IN 2023
  • FIGURE 11 GROWING DEMAND FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO OFFER LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 12 PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 13 LIQUID SEGMENT TO EXHIBIT HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 14 INDIA TO REGISTER HIGHEST CAGR IN GLOBAL MARKET DURING FORECAST PERIOD
  • FIGURE 15 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF DRIVERS
  • FIGURE 17 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF RESTRAINTS
  • FIGURE 18 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF OPPORTUNITIES
  • FIGURE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF CHALLENGES
  • FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 21 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019-2023
  • FIGURE 22 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, BY REGION, 2019-2023
  • FIGURE 23 VALUE CHAIN ANALYSIS
  • FIGURE 24 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET ECOSYSTEM ANALYSIS
  • FIGURE 25 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • FIGURE 26 PATENTS APPLIED AND GRANTED, 2014-2023
  • FIGURE 27 IMPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023
  • FIGURE 28 EXPORT DATA FOR HS CODE 842230-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023
  • FIGURE 29 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT FOR END-PRODUCT TYPE
  • FIGURE 31 KEY BUYING CRITERIA FOR PHARMACEUTICAL MANUFACTURING EQUIPMENT FOR END-PRODUCT TYPES
  • FIGURE 32 SOLID SEGMENT TO HOLD LARGER MARKET SHARE IN 2024
  • FIGURE 33 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
  • FIGURE 34 PACKAGING MACHINES TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 35 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION
  • FIGURE 36 ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
  • FIGURE 37 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 38 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 40 SOUTH AMERICA TO DOMINATE MARKET IN ROW REGION IN 2024
  • FIGURE 41 PHARMACEUTICAL PACKAGING MACHINES MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS OFFERING PHARMACEUTICAL PACKAGING MACHINES, 2023
  • FIGURE 43 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY VALUATION, 2024
  • FIGURE 44 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: FINANCIAL METRICS (EV/EBITDA), 2024
  • FIGURE 45 PHARMACEUTICAL PACKAGING MACHINES MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 46 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 47 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY FOOTPRINT
  • FIGURE 48 PHARMACEUTICAL PACKAGING MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 49 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
  • FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 51 KORBER AG: COMPANY SNAPSHOT